Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer's disease, by combining computational methods and lab research.

13 Jan 2020

Study may provide novel targetable mechanisms of therapeutic resistance to anti-VEGF therapies

To establish a molecular signature of this resistance in ovarian cancer, the authors developed preclinical tumor models of adaptive resistance to chronic anti-VEGF treatment.

8 Jan 2020

Study finds no significant link between using talc and ovarian cancer risk

Largest reported investigation to date shows no significant association between talcum powder and increased ovarian cancer risk.

8 Jan 2020

Phase II case-control trial initiated for four types of terminal cancers

The Alexandrov National Cancer Centre begins phase II case-control clinical trial of its immuno-oncology agent, Elenagen.

7 Jan 2020

A new book on ovarian cancer

An opening discussion of contemporary management of this disease presents commentary on surgery and clinical trials: neoadjuvant, dose-dense, and heated intraperitoneal chemotherapy (HIPEC}, as well as immunotherapy, vaccine therapy, emerging therapies.

18 Dec 2019

NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

The National Comprehensive Cancer Network (NCCN) hosted an annual NCCN Patient Advocacy Summit: Delivering Value for Patients across the Oncology Ecosystem in Washington, DC, today.

11 Dec 2019

Small, thin metal mesh loaded with T cells shrinks tumors in ovarian cancer models

New findings published Dec. 9 in Nature Biomedical Engineering from scientists at Fred Hutchinson Cancer Research Center show for the first time that a piece of small, thin metal mesh loaded with cancer-fighting immune cells shrinks tumors in preclinical models of ovarian cancer.

9 Dec 2019

Overabundance of novel gene in aggressive form of ovarian cancer may serve as prognostic tool

Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool.

5 Dec 2019

Cedars-Sinai surgeons detect and remove 25-pound cancerous ovarian tumor

Maria Robles Garcia was sure her uncomfortable abdominal symptoms weren't caused by irritable bowel syndrome or from being overweight, no matter that her local doctors repeatedly told her that was the case.

13 Nov 2019

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.

13 Nov 2019

Experimental drug targets currently untreatable type of lung cancer

Scientists at Stanford and UC-San Francisco have developed an experimental drug that targets a currently untreatable type of lung cancer responsible for generating roughly 500,000 newly diagnosed cases worldwide each year.

7 Nov 2019

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Using cells from human breast cancers and mouse breast cancer models, researchers at the Johns Hopkins Kimmel Cancer Center say they have significant new evidence that tumor cells exposed to low-oxygen conditions have an advantage when it comes to invading and surviving in the bloodstream.

7 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

3D-printed cell traps help researchers remove the hay to expose cancer cells

Finding a handful of cancer cells hiding among billions of blood cells in a patient sample can be like finding a needle in a haystack. In a new approach enabled by 3D-printed cell traps, researchers are removing the hay to expose the cancer cells.

28 Oct 2019

Genetically definable subgroups of cancers sensitive to treatment

Precision oncology aims to use genetic features of a patient's tumor to tailor anti-cancer therapy. DNA mutations in a drug target have provided a number of therapeutic opportunities; however, there are many cancer types that do not have obvious targetable mutations.

24 Oct 2019

Cooperative research center at LLNL aims to develop vaccines for chlamydia

A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.

24 Oct 2019

Cleveland Clinic announces Top 10 Medical Innovations for 2020

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

23 Oct 2019

Yale scientists build powerful genomic research platform to study cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.

17 Oct 2019

Chemists find new way to synthesize most common molecule arrangement in medicine

Organic chemists at The Ohio State University have figured out how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs - including one most commonly used to treat ovarian cancer - are produced.

17 Oct 2019

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

Marshall University Joan C. Edwards School of Medicine has received a five-year, $17 million award from the National Institutes of Health for continued funding of West Virginia IDeA Network of Biomedical Research Excellence.

15 Oct 2019

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

Study may provide novel targetable mechanisms of therapeutic resistance to anti-VEGF therapies

Study finds no significant link between using talc and ovarian cancer risk

Phase II case-control trial initiated for four types of terminal cancers

A new book on ovarian cancer

NCCN Patient Advocacy Summit closes gaps in perspective of value in cancer care

Small, thin metal mesh loaded with T cells shrinks tumors in ovarian cancer models

Overabundance of novel gene in aggressive form of ovarian cancer may serve as prognostic tool

Cedars-Sinai surgeons detect and remove 25-pound cancerous ovarian tumor

Secondary surgery for recurrent ovarian cancer patients does not result in longer survival

Experimental drug targets currently untreatable type of lung cancer

Oxygen-deprived tumor cells have survival advantage that promotes metastasis

Nanotechnologies can lead to big advances in cancer therapy

3D-printed cell traps help researchers remove the hay to expose cancer cells

Genetically definable subgroups of cancers sensitive to treatment

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Cleveland Clinic announces Top 10 Medical Innovations for 2020

Yale scientists build powerful genomic research platform to study cervical cancer

Chemists find new way to synthesize most common molecule arrangement in medicine

Marshall receives $17 million renewal funding for biomedical research efforts in West Virginia

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in